Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
19.32B | 19.85B | 21.66B | 18.45B | 13.66B | 14.54B | Gross Profit |
11.52B | 14.55B | 13.41B | 11.42B | 8.05B | 8.55B | EBIT |
3.80B | 4.47B | 4.04B | 3.84B | 2.37B | 3.24B | EBITDA |
6.68B | 6.83B | 5.59B | 6.04B | 3.93B | 3.83B | Net Income Common Stockholders |
1.81B | 2.29B | 7.80B | 2.35B | 1.64B | 1.26B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.77B | 4.25B | 2.77B | 3.35B | 2.50B | 2.07B | Total Assets |
92.70B | 98.33B | 92.70B | 94.86B | 67.22B | 67.56B | Total Debt |
40.44B | 47.07B | 42.98B | 45.47B | 31.22B | 30.79B | Net Debt |
40.27B | 46.52B | 42.82B | 45.26B | 31.06B | 30.72B | Total Liabilities |
63.13B | 68.43B | 63.13B | 71.00B | 47.36B | 47.77B | Stockholders Equity |
29.54B | 29.87B | 29.54B | 23.83B | 19.84B | 19.77B |
Cash Flow | Free Cash Flow | ||||
-989.00M | -514.00M | 573.00M | -119.00M | -804.00M | -1.09B | Operating Cash Flow |
6.69B | 6.94B | 6.90B | 5.42B | 3.80B | 3.81B | Investing Cash Flow |
-11.48B | -7.50B | 240.00M | -14.22B | -5.21B | -3.34B | Financing Cash Flow |
5.96B | 987.00M | -7.17B | 8.82B | 1.50B | -649.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $47.93B | 21.09 | 8.22% | 4.75% | 3.62% | 40.33% | |
74 Outperform | $44.81B | 16.47 | 10.10% | 3.47% | 6.71% | 16.09% | |
73 Outperform | $70.32B | 18.42 | 8.31% | 4.81% | -3.25% | -76.46% | |
69 Neutral | $55.44B | 20.02 | 10.41% | 3.49% | 4.20% | -3.64% | |
69 Neutral | $41.65B | 21.34 | 10.26% | 3.06% | -0.44% | 2.14% | |
65 Neutral | $39.81B | 21.81 | 11.40% | 3.05% | 11.24% | 1.15% | |
63 Neutral | $8.57B | 10.13 | 4.66% | 4.38% | 3.79% | -12.91% |